Skip to main content
Premium Trial:

Request an Annual Quote

Warnex to Acquire Molecular World for $629K

NEW YORK (GenomeWeb News) – Warnex said yesterday that it has signed an agreement in principle to acquire a DNA identification lab called Molecular World for 2 million of its common shares and the assumption of around C$350,000.

Based on Warnex's closing price of C$.175 on the Toronto Stock Exchange yesterday, the deal is valued at roughly C$700,000 (US$629,000).

"The acquisition of Molecular World will expand Warnex's DNA identification services, particularly in the forensic testing field, and provide us with a unique expertise," Mark Busgang, president and CEO of Laval, Quebec-based Warnex, said in a statement. "Molecular World is the only private laboratory in Canada providing STR, Y-STR, miniSTR, and mitochondrial DNA testing services for forensic and parentage testing purposes."

Thunder Bay, Ontario-based Molecular World had revenues of C$544,000 in its last fiscal year. Warnex said that the lab would operate as a subsidiary and remain in its current facilities.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.